Specialist initiation and monitoring of beta blockers in patients with chronic heart failure and concomitant obstructive airways disease

被引：3
作者：
Critchley, W. R. [1 ,2 ]
Al-Sheklly, B. [2 ]
Sekar, B. [2 ]
Coppinger, T. [3 ]
Waywell, C. [3 ]
Leonard, C. T. [2 ]
Niven, R. [4 ]
Williams, S. G. [3 ]
Shaw, S. M. [3 ]
机构：
[1] Univ Manchester, Inst Inflammat & Repair, Manchester M13 9LP, Lancs, England
[2] Univ Hosp South Manchester NHS Fdn Trust, Wythenshawe Hosp, Transplant Ctr, Manchester M23 9LT, Lancs, England
[3] Univ Hosp South Manchester NHS Fdn Trust, Wythenshawe Hosp, Manchester Acad Hlth Sci Ctr, Manchester M23 9LT, Lancs, England
[4] Univ Hosp South Manchester NHS Fdn Trust, Wythenshawe Hosp, North West Lung Ctr, Manchester M23 9LT, Lancs, England
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 167卷 / 05期
关键词：
Chronic heart failure; Beta blockers; Nebivolol; COPD; Asthma; Airways disease exacerbation; CARVEDILOL; MORTALITY;
D O I：
10.1016/j.ijcard.2012.11.057
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2361 / 2363
页数：3
相关论文
共 50 条
  • [1] Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction
    Mtisi, Tafadzwa F.
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2020, 28 (01) : 20 - 25
  • [2] Beta-Adrenergic Blockers for Chronic Heart Failure
    Javed, Usman
    Deedwania, Prakash C.
    CARDIOLOGY IN REVIEW, 2009, 17 (06) : 287 - 292
  • [3] Differences between beta-blockers in patients with heart failure and chronic obstructive pulmonary disease
    Di Tano, Giuseppe
    Frattini, Silvia
    Pirelli, Salvatore
    GIORNALE ITALIANO DI CARDIOLOGIA, 2011, 12 (09) : 588 - 595
  • [4] Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
    Lipworth, Brian
    Skinner, Derek
    Devereux, Graham
    Thomas, Victoria
    Jie, Joanna Ling Zhi
    Martin, Jessica
    Carter, Victoria
    Price, David B.
    HEART, 2016, 102 (23) : 1909 - 1914
  • [5] Beta-Blockers and Weight Change in Patients With Chronic Heart Failure
    Boxall, Ben W. J.
    Clark, Andrew L.
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (03) : 233 - 237
  • [6] Beta-blockers for the treatment of elderly patients with coexisting heart failure and chronic obstructive pulmonary disease
    Komici, K.
    Furgi, G.
    Vitale, D. F.
    Rengo, F.
    GIORNALE DI GERONTOLOGIA, 2015, 63 (02) : 69 - 75
  • [7] The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure
    Lainscak, Mitja
    Hodoscek, Lea Majc
    Duengen, Hans-Dirk
    Rauchhaus, Mathias
    Doehner, Wolfram
    Anker, Stefan D.
    von Haehling, Stephan
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (9-10) : 309 - 313
  • [8] The role of beta-blockers in outcomes of patients hospitalized for heart failure and chronic obstructive pulmonary disease
    Rutten, Frans H.
    Gueder, Guelmisal
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (07) : 849 - 850
  • [9] The role of beta-blockers in the management of chronic obstructive pulmonary disease
    Leitao Filho, Fernando Sergio
    Alotaibi, Nawaf M.
    Yamasaki, Kei
    Ngan, David A.
    Sin, Don D.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2018, 12 (02) : 125 - 135
  • [10] beta-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease
    Rutten, Frans H.
    FUTURE CARDIOLOGY, 2011, 7 (01) : 43 - 53
12345